Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms

Article ID	Journal	Published Year	Pages	File Type
8540454	Vascular Pharmacology	2018	24 Pages	PDF

Keywords

VKA MDR1 Acenocoumarol VKORC1 Hmb CYP4F2 Vitamin K Epoxide Reductase Complex Subunit 1 GGCX INR CYP2C9 IQR TTR VTE AUC Pulmonary embolism vitamin K antagonists vitamin K antagonist Apoe apolipoprotein E standard deviation Venous thromboembolism Deep vein thrombosis DVT Heavy menstrual bleeding Time in therapeutic range confidence interval Atrial fibrillation interquartile range area under the curve odds ratio International Normalized Ratio Warfarin Genetic polymorphisms Single nucleotide polymorphism SNP multidrug resistance gene 1 gamma-glutamyl carboxylase

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms

Authors

Agata Hanna Bryk, Ewa Wypasek, Krzysztof Plens, Magdalena Awsiuk, Anetta Undas,